Greenbrook TMS Inc. Stock Analysis GBNHF

Greenbrook Tms, Inc. engages in the control and operation of a network of outpatient mental health services centers that specialize in the provision of Transcranial Magnetic Stimulation (TMS) therapy and other treatment modalities for the treatment of depression and related psychiatric services. The company is headquartered in Toronto, Ontario. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. The firm operates a network of outpatient mental health service centers that specialize in treatment across the United States. The company offers Treatment Centers in convenient locations to provide easy access to patients and clinicians. The firm owns and operates 130 Treatment Centers in the Commonwealths of Massachusetts, Virginia and Pennsylvania and the States of Maryland, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, and Michigan.